Comparative Effects of Moxonidine and Bisoprolol on Bone Metabolism, Vascular and Cellular Markers of Aging, Blood Pressure in Hypertensive Postmenopausal Women (COMPASS)

Trial Profile

Comparative Effects of Moxonidine and Bisoprolol on Bone Metabolism, Vascular and Cellular Markers of Aging, Blood Pressure in Hypertensive Postmenopausal Women (COMPASS)

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 01 Dec 2017

At a glance

  • Drugs Moxonidine (Primary) ; Bisoprolol
  • Indications Hypertension; Metabolic bone diseases
  • Focus Biomarker; Pharmacodynamics
  • Acronyms COMPASS
  • Most Recent Events

    • 28 Nov 2017 Planned End Date changed from 1 Oct 2017 to 1 Dec 2017.
    • 28 Nov 2017 Planned primary completion date changed from 1 Sep 2017 to 1 Dec 2017.
    • 28 Nov 2017 Status changed from recruiting to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top